Philadelphia Public Health Advisory: Increase in New HIV Diagnoses Among Injectable Drug Users

Published on June 21, 2022

CBH encourages providers to review the Philadelphia Department of Public Health’s advisory about recent increases in new HIV diagnosis among people who inject drugs. The advisory includes information about the increase and recommendations for testing, reporting, prompt linkage to treatment, harm reduction services, and referrals for post-exposure prophylaxis.

Reference: PDPH Advisory: Increase in New HIV Diagnoses among People who Inject Drugs